Notice Number: NOT-OD-20-036
Key Dates
Release Date: December 4, 2019
PAR-18-846
Issued by
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
National Institute on Drug Abuse (NIDA)
Purpose
The purpose of this Notice is to inform interested applicants of two additional receipt dates for the Funding Opportunity Announcement (FOA) PAR-18-846 “PAR-18-846 “Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 Clinical Trial Not Allowed)” on October 26, 2020 and June 25, 2021.
As a result, the Key Dates section of the FOA has been modified as follows:
Part 1. Overview Information
Key Dates
Currently Reads:
Application Due Date(s)
October 24, 2018; June 27, 2019; October 24, 2019; June 27, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not Applicable.
Scientific Merit Review
Advisory Council Review
May 2019; January 2020; May 2020; January 2021
Earliest Start Date
Expiration Date
June 28, 2020
Modified to Read:
Application Due Date(s)
October 24, 2018; June 27, 2019; October 24, 2019; June 27, 2020; October 26, 2020; June 25, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not Applicable
Scientific Merit Review
Advisory Council Review
May 2019; January 2020; May 2020; January 2021; May 2021; January 2022
Earliest Start Date
Expiration Date
June 26, 2021
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Mary L. Garcia-Cazarin, MS, PhD
Office of Disease Prevention (ODP)
Telephone: 301-451-2937
Email: [email protected]
and Human Services (HHS)
